Pfizer Discontinues Sutent Colon Cancer Study
Save Email Print
Pfizer Discontinues Sutent Colon Cancer Study
Pfizer is discontinuing a late-stage study of its cancer drug Sutent (SOO-tent) as an initial treatment for colon cancer because the drug is not proving effective enough.
Reporter: Associated Press
Email Address: news@kake.com
width:202 and height: 151 and picwidth: 202 and pciheight: 151
Post Your Comments
First Name:
Location:
Enter Comments: characters left
Email (optional):
By posting this comment I have read and agree to the Terms of Use and Privacy Policy:
You must agree to the Terms of Service to continue.